Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.

The sand flea Tunga penetrans is one of the zoonotic agents of tungiasis, a parasitic skin disease of humans and animals. The dog is one of its main reservoirs. This negatively controlled, randomized, double-masked clinical trial evaluated the therapeutic and residual efficacy of fluralaner for trea...

Full description

Bibliographic Details
Main Authors: Katharine Costa Dos Santos, Rafael Marin Chiummo, Anja Regina Heckeroth, Eva Zschiesche, Paula Elisa Brandão Guedes, Tatiani Vitor Harvey, Anderson Vieira de Jesus, Anaiá da Paixão Sevá, Joana Thaisa Santos de Oliveira, Zelina Dos Santos Freire, Jürgen Krücken, Fernando de Almeida Borges, Georg von Samson-Himmelstjerna, Renata Santiago Alberto Carlos
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-03-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0010251
_version_ 1818285695955894272
author Katharine Costa Dos Santos
Rafael Marin Chiummo
Anja Regina Heckeroth
Eva Zschiesche
Paula Elisa Brandão Guedes
Tatiani Vitor Harvey
Anderson Vieira de Jesus
Anaiá da Paixão Sevá
Joana Thaisa Santos de Oliveira
Zelina Dos Santos Freire
Jürgen Krücken
Fernando de Almeida Borges
Georg von Samson-Himmelstjerna
Renata Santiago Alberto Carlos
author_facet Katharine Costa Dos Santos
Rafael Marin Chiummo
Anja Regina Heckeroth
Eva Zschiesche
Paula Elisa Brandão Guedes
Tatiani Vitor Harvey
Anderson Vieira de Jesus
Anaiá da Paixão Sevá
Joana Thaisa Santos de Oliveira
Zelina Dos Santos Freire
Jürgen Krücken
Fernando de Almeida Borges
Georg von Samson-Himmelstjerna
Renata Santiago Alberto Carlos
author_sort Katharine Costa Dos Santos
collection DOAJ
description The sand flea Tunga penetrans is one of the zoonotic agents of tungiasis, a parasitic skin disease of humans and animals. The dog is one of its main reservoirs. This negatively controlled, randomized, double-masked clinical trial evaluated the therapeutic and residual efficacy of fluralaner for treatment of dogs naturally infested with T. penetrans. Sixty-two dogs from an endemically affected community in Brazil were randomly assigned to either receive oral fluralaner (Bravecto chewable tablets) at a dose of 25 to 56 mg fluralaner/kg body weight, or no treatment (31 dogs per group). Dogs were clinically examined using a severity score for acute canine tungiasis (SCADT), parasitological examinations as defined by the Fortaleza classification, and pictures of lesions on days 0 (inclusion and treatment), 7 ± 2, 14 ± 2, 21 ± 2, 28 ± 2, 60 ± 7, 90 ± 7, 120 ± 7 and 150 ± 7. The percentage of parasite-free dogs after treatment was >90% between days 14 and 90 post-treatment with 100% efficacy on study days 21, 28 and 60. Sand flea counts on fluralaner treated dogs were significantly lower (p<0.025) than control dogs on all counts from day 7 to 120. The number of live sand fleas on treated dogs was reduced by > 90% on day 7, > 95% on days 14 and 90, and 100% from day 21 to 60, and with a significant difference between groups from day 7 to 120. From day 7 to day 120, mean SCADT scores were significantly reduced in treated dogs with a mean of 0.10 compared to 1.54 on day 120 in untreated dogs. Therefore, a single oral fluralaner administration is effective for treating and achieving long lasting (> 12 weeks) prevention for tungiasis in dogs.
first_indexed 2024-12-13T01:12:48Z
format Article
id doaj.art-56c84fff95e94b7196f6be9811747b38
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-13T01:12:48Z
publishDate 2022-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-56c84fff95e94b7196f6be9811747b382022-12-22T00:04:26ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352022-03-01163e001025110.1371/journal.pntd.0010251Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.Katharine Costa Dos SantosRafael Marin ChiummoAnja Regina HeckerothEva ZschieschePaula Elisa Brandão GuedesTatiani Vitor HarveyAnderson Vieira de JesusAnaiá da Paixão SeváJoana Thaisa Santos de OliveiraZelina Dos Santos FreireJürgen KrückenFernando de Almeida BorgesGeorg von Samson-HimmelstjernaRenata Santiago Alberto CarlosThe sand flea Tunga penetrans is one of the zoonotic agents of tungiasis, a parasitic skin disease of humans and animals. The dog is one of its main reservoirs. This negatively controlled, randomized, double-masked clinical trial evaluated the therapeutic and residual efficacy of fluralaner for treatment of dogs naturally infested with T. penetrans. Sixty-two dogs from an endemically affected community in Brazil were randomly assigned to either receive oral fluralaner (Bravecto chewable tablets) at a dose of 25 to 56 mg fluralaner/kg body weight, or no treatment (31 dogs per group). Dogs were clinically examined using a severity score for acute canine tungiasis (SCADT), parasitological examinations as defined by the Fortaleza classification, and pictures of lesions on days 0 (inclusion and treatment), 7 ± 2, 14 ± 2, 21 ± 2, 28 ± 2, 60 ± 7, 90 ± 7, 120 ± 7 and 150 ± 7. The percentage of parasite-free dogs after treatment was >90% between days 14 and 90 post-treatment with 100% efficacy on study days 21, 28 and 60. Sand flea counts on fluralaner treated dogs were significantly lower (p<0.025) than control dogs on all counts from day 7 to 120. The number of live sand fleas on treated dogs was reduced by > 90% on day 7, > 95% on days 14 and 90, and 100% from day 21 to 60, and with a significant difference between groups from day 7 to 120. From day 7 to day 120, mean SCADT scores were significantly reduced in treated dogs with a mean of 0.10 compared to 1.54 on day 120 in untreated dogs. Therefore, a single oral fluralaner administration is effective for treating and achieving long lasting (> 12 weeks) prevention for tungiasis in dogs.https://doi.org/10.1371/journal.pntd.0010251
spellingShingle Katharine Costa Dos Santos
Rafael Marin Chiummo
Anja Regina Heckeroth
Eva Zschiesche
Paula Elisa Brandão Guedes
Tatiani Vitor Harvey
Anderson Vieira de Jesus
Anaiá da Paixão Sevá
Joana Thaisa Santos de Oliveira
Zelina Dos Santos Freire
Jürgen Krücken
Fernando de Almeida Borges
Georg von Samson-Himmelstjerna
Renata Santiago Alberto Carlos
Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.
PLoS Neglected Tropical Diseases
title Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.
title_full Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.
title_fullStr Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.
title_full_unstemmed Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.
title_short Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil.
title_sort efficacy of oral fluralaner bravecto against tunga penetrans in dogs a negative control randomized field study in an endemic community in brazil
url https://doi.org/10.1371/journal.pntd.0010251
work_keys_str_mv AT katharinecostadossantos efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT rafaelmarinchiummo efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT anjareginaheckeroth efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT evazschiesche efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT paulaelisabrandaoguedes efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT tatianivitorharvey efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT andersonvieiradejesus efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT anaiadapaixaoseva efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT joanathaisasantosdeoliveira efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT zelinadossantosfreire efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT jurgenkrucken efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT fernandodealmeidaborges efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT georgvonsamsonhimmelstjerna efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil
AT renatasantiagoalbertocarlos efficacyoforalfluralanerbravectoagainsttungapenetransindogsanegativecontrolrandomizedfieldstudyinanendemiccommunityinbrazil